Archives
-
3-Bromopyruvate Restores Cetuximab Sensitivity via Ferroptos
2026-06-13
This study uncovers how 3-bromopyruvate (3-BP) overcomes cetuximab resistance in colorectal cancer cells by promoting autophagy-dependent ferroptosis and apoptosis. The findings provide mechanistic insight into drug resistance and suggest co-treatment as a promising therapeutic approach.
-
Ordered DNA Nanostructures Boost Enzymatic Oligonucleotide S
2026-06-12
This study introduces a tetrahedral DNA framework that organizes primer orientation and spacing to enhance enzymatic oligonucleotide synthesis (EOS) efficiency and fidelity. The approach significantly improves enzyme accessibility and reduces deletion errors, offering new potential for high-yield, accurate DNA synthesis in applications such as DNA data storage.
-
RG7388 MDM2 Antagonist: Applied Protocols & Troubleshooting
2026-06-12
RG7388, a next-generation MDM2 antagonist, drives precise p53 pathway activation and robust apoptosis in wild-type p53 cancer models. This article delivers stepwise workflows, advanced use-cases, and troubleshooting strategies, translating the latest biomarker insights into optimized experimental success.
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor Pr
2026-06-11
Wang et al. (2018) systematically elucidated the cellular entry mechanism of genotype III grass carp reovirus (GCRV104), demonstrating that clathrin-mediated endocytosis—but not actin cytoskeleton disruption—governs viral internalization in CIK cells. Their integrative inhibitor analysis refines current models of viral entry and provides a robust framework for future cytoskeletal and virological research.
-
Ibrexafungerp and Caspofungin Efficacy Against Resistant C.
2026-06-11
Wiederhold et al. demonstrate that ibrexafungerp, a first-in-class triterpenoid antifungal, exhibits potent in vitro and in vivo activity against fluconazole-resistant Candida auris, including when treatment is delayed. The study validates the utility of targeting β-(1,3)-D-glucan biosynthesis and highlights continued roles for lipopeptide antifungals like caspofungin in antifungal resistance research.
-
Bradykinin B2 Receptors Inhibit Ileal Peristalsis: Mechanist
2026-06-10
This study demonstrates that bradykinin B2 receptor activation significantly inhibits the peristaltic reflex in the guinea pig ileum, raising the pressure threshold for peristalsis. The findings provide mechanistic clarity on gastrointestinal motility modulation and inform future research on ACE inhibition and bradykinin signaling.
-
HDAC3 Modulates TPM3 Khib in Vascular Smooth Muscle Contract
2026-06-10
The referenced study reveals that histone deacetylase 3 (HDAC3) controls vasoconstriction by erasing 2-hydroxyisobutyrylation (Khib) on tropomyosin 3 (TPM3) at lysine 141, identifying a novel epigenetic regulatory axis in vascular smooth muscle cells. This mechanistic insight suggests new avenues for therapeutic intervention in hypertension and vascular dysfunction.
-
Hydroxytyrosol: Mechanistic Leverage for Translational Resea
2026-06-09
This thought-leadership article explores the biological and translational potential of Hydroxytyrosol (4-(2-hydroxyethyl)benzene-1,2-diol), moving beyond standard product summaries to deliver actionable insights for researchers. By rigorously synthesizing mechanistic findings, protocol guidance, and strategic considerations, it positions Hydroxytyrosol—especially in its high-purity APExBIO form—as a linchpin for innovation in oxidative stress, cardiovascular, and inflammation research.
-
EdU Flow Cytometry Assay Kits (Cy5): Practical Protocol Guid
2026-06-09
The EdU Flow Cytometry Assay Kits (Cy5) address the challenge of quantifying S-phase DNA synthesis in proliferating cells, streamlining cell proliferation analysis without requiring harsh DNA denaturation. This kit is most suitable for flow cytometry-based cell cycle studies and pharmacodynamic research, but is not recommended for applications needing live-cell imaging or where copper catalysis is incompatible.
-
Pravastatin Sodium: Applied Protocols for HMG-CoA Reductase
2026-06-08
Leverage Pravastatin sodium for reliable cholesterol biosynthesis inhibition across diverse experimental models. This guide delivers actionable protocols, troubleshooting insights, and translational strategies—backed by APExBIO quality—for researchers aiming for robust cardiovascular and metabolic studies.
-
Fenofibrate as a PPARα Agonist: Advanced Insights for Liver
2026-06-08
Explore how Fenofibrate, a potent PPARα agonist, drives both liver enlargement and cytotoxicity in cancer models. This article unveils new mechanistic and translational insights for lipid metabolism and cancer biology research.
-
Dihydroethidium (DHE) in Mitochondrial ROS Assays: Advanced
2026-06-07
Explore the advanced use of Dihydroethidium in mitochondrial ROS and apoptosis assays. This article uncovers unique methodological insights and translational applications, distinguishing it from standard DHE guides.
-
Antipyrine (SKU B1886): Reliable Assays for BBB and CNS Rese
2026-06-06
This article delivers scenario-driven guidance for biomedical researchers using Antipyrine (SKU B1886) in cell viability, BBB permeability, and pharmacokinetic workflows. Drawing on recent literature and validated product data, it highlights how APExBIO’s Antipyrine enables reproducible, high-fidelity CNS assay results and addresses common challenges in compound selection, solubility, and data interpretation.
-
Trichostatin A (TSA): Redefining HDAC Inhibition for Bone an
2026-06-05
Explore how Trichostatin A (TSA), a potent HDAC inhibitor, is reshaping both epigenetic cancer research and bone regeneration by bridging molecular insights with translational applications. Discover unique mechanistic findings, practical workflow guidance, and the latest evidence on TSA’s dual impact.
-
Hydroxychloroquine Sulfate: Protocols for Autoimmune Disease
2026-06-05
Hydroxychloroquine Sulfate (SKU B4874) is designed for precise inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, particularly for systemic lupus erythematosus and rheumatoid arthritis models. It is best suited for aqueous protocols and should not be used in workflows requiring organic solvent solubility or long-term solution storage.